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Bacterial and yeast strains  
The following bacteria and yeast strains were used: XL2-Blue (E. coli recA1 endA1 gyrA96 thi-
1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZM15 Tn10 (Tetr) Amy Camr]), BL21-RIL (E. coli B F–
ompT hsdS(rB
– mB
–) dcm+ Tetr gal endA Hte [argU ileY leuW Camr]) and BSY1883 (S. cerevisiae ade 
2-1 his3-11,15 leu2-3,112 trp1 ura3-1 can1-100 KanMX6:TetOFF-DIS3, rrp6::URA3).
Oligonucleotides, plasmids and cloning
Oligonucleotides and plasmids used are listed in Supplementary Tables S4 and S5, respectively. 
All restriction enzymes, T4 DNA ligase and CIAP were from Fermentas. All DNA purification kits: 
DNA Plasmid Mini, DNA Plasmid Midi and Gel-Out were from A&A Biotechnology. PCR reactions 
were performed with the Phusion DNA polymerase (Finnzymes) or Pfu DNA polymerase (Fermentas). 
Inserts of all the obtained plasmids were sequenced.  
The cDNA clones of hDIS3 and hDIS3L were purchased from RZPD (respective imaGenes 
catalogue numbers: DKFZp667L1817Q and IMAGp998A2015767Q). The hDIS3L cDNA bore one 
silent mutation, T1221C, which was ignored. 
Plasmid pDrK (kindly provided by Dr. Monika Hejnowicz) was generated from pDRIVE 
(Qiagen). Plasmid pRS72 was created as follows: the TAP-tag coding sequence was PCR-amplified 
2using the RSZ169 and RZS168 primer pair. The insert was ligated into pDrK digested with EcoRV, 
and subsequently cut out with XhoI and ApaI and ligated with likewise digested pcDNA5/FRT/TO 
(Invitrogen). Plasmids pRS201 and pRS255 were generated by annealing oligonucleotide pairs 
RSZ143-RSZ144 and RSZ132-RSZ133, respectively, and ligating the resulting duplexes with ApaI- 
digested pcDNA5/FRT/TO. Plasmids pHEX1 and pHEX2 were generated by inserting hDIS3 and 
hDIS3L open-reading frames amplified from RZPD cDNA clones (see above) using primer pairs 
SLICD3f-SLICD3r and SLICD3lf-SLICD3lr, respectively, into BamHI and XhoI sites of the pET-
28M-6xHis-SUMOTag vector (Lebreton et al, 2008; Malakhov et al, 2004). The sequence and ligation 
independent cloning (SLIC) technique (Li and Elledge, 2007) was employed. pHEX1 and pHEX2 then 
served as the PCR templates for all remaining hDIS3 and hDIS3L constructs. Plasmids pHEX3 and 
pHEX4 were obtained by PCR using primer pairs HD3NFor-HD3NRev and HD3NFor-HD3LNRev 
with pHEX1 and pHEX2 as templates, followed by ligation of amplification products with T4 DNA 
ligase in the presence of T4 polynucleotide kinase (NEB) and ATP. Plasmids pHEX5 and pHEX6 were 
created similarly with the same templates, using HD3CFor-HD3CRev and HD3LCFor-HD3CRev 
primer pairs, respectively. Plasmids pHEX7 and pHEX13 were generated by site-directed mutagenesis 
with oligonucleotides D3PINF-D3PINR, using pHEX1 or pHEX3 as templates, respectively. pHEX8 
and pHEX14 were obtained by site-directed mutagenesis with oligonucleotides D3RNBF-D3RNBR, 
employing pHEX1 or pHEX5 as templates. D146N and D487N mutations in hDIS3 were confirmed by 
PCR with primers SumoF-RTADZ-54, followed by digestion with MspI or Eco32I, respectively. 
Plasmids pHEX10 and pHEX15 were created by site-directed mutagenesis with oligonucleotides 
D3LPINF-D3LPINR, using pHEX2 or pHEX4 as templates, respectively. pHEX11 and pHEX16 were 
constructed by site-directed mutagenesis with oligonucleotides D3LRNBF-D3LRNBR, employing 
pHEX2 or pHEX6 as templates. D62N and D486N mutations in hDIS3L were confirmed by PCR with 
primers SumoF-RTADZ-54, followed by digestion with MunI or AatII, respectively. Plasmids pHEX9 
and pHEX12 were generated by site-directed mutagenesis with primer pairs D3RNBF-D3RNBR and 
3D3LRNBF-D3LRNBR, using pHEX7 and pHEX10 as templates, respectively. Plasmids pHEX17, 
pHEX19 and pHEX21 were created in the pRS255, pRS201, and pRS72 vectors, respectively. The 
coding sequence of hDIS3L was PCR-amplified using the dis3l-tap-fw and dis3l-tap-rv primer pair 
with pHEX2 as template. The PCR product was gel-purified with the Gel-Out kit and ligated with 
pDrK digested with SnaBI. The ligation reaction mixture was treated with SnaBI and transformed into 
home-made XL2-Blue chemocompetent bacteria (Stratagene). The insert sequence was cut out with 
Acc65I and XhoI, gel-purified, and ligated with vectors, which had been similarly digested, 
dephosphorylated with CIAP and gel-purified. Plasmids pHEX18 and pHEX20 were created like 
pHEX19 and pHEX21, but the hDIS3 coding sequence was PCR-amplified using the dis3-tap-fw and 
dis3-tap-rv primer pair with pHEX1 as template. Plasmid pHEX22 was obtained by cloning the hDIS3 
open reading frame amplified using the D3COMPL-D3COMPR primer pair and pHEX1 as template 
into the XbaI and XhoI sites of the p415 vector. Plasmid pHEX23 was created by cloning the hDIS3L 
open reading frame amplified with the use of D3LCOMPL-D3LCOMPR primer pair and pHEX2 as 
template into the SpeI and XhoI sites of p415. Plasmids pHEX24 and pHEX25 were generated by site-
directed mutagenesis of the pHEX25 template, using D3RNBF-D3RNBR and D3PINF-D3PINR 
oligonucleotide pairs, respectively. Plasmid pHEX26 was constructed by site-directed mutagenesis 
with oligonucleotides D3RNBF-D3RNBR, employing pHEX25 as a template. Plasmids pHEX27 and 
pHEX28 were obtained by site-directed mutagenesis with D3RNBF-D3RNBR oligonucleotides, using 
pHEX18 or pHEX20 as templates, respectively. Plasmid pHEX29 was generated by site-directed 
mutagenesis with D3PINF-D3PINR oligonucleotide pair with pHEX28 as a template. Plasmid pHEX30 
was created by site-directed mutagenesis with D3LRNBF-D3LRNBR oligonucleotides, employing 
pHEX21 as a template. Plasmid pHEX31 was constructed by site-directed mutagenesis with D3LPINF-
D3LPINR oligonucleotide pair with pHEX30 as a template. Plasmids pHEX32 and pHEX33 were 
constructed by inserting hRRP6 and hRRP41 open-reading frames amplified using primer pairs hRRP6 
BamHI FW-hRRP6 FLAG NotI RE or hRRP41 BamHI FW-hRRP41 FLAG NotI RE with either 
4pEGFP-N1-PM/SCl-100 plasmid (kind gift from Dr Ger Pruijn) or oligo-dT-primed cDNA from 
HEK293T cells as templates, respectively, into BamHI and NotI sites of pcDNA5/FRT/TO vector 
(Invitrogen). Plasmid pHEX34 was generated by mutagenesis using hD3Fup-hD3Fdwn primer pair and 
pHEX22 as a template. Plasmid pHEX35 was obtained by cloning the hDIS3L open reading frame 
amplified using the D3LCOMPL-hD3LFrev primer pair and pHEX23 as template into the SpeI and 
XhoI sites of the p415 vector.   
Cell culture and transfection 
HeLa or HEK293 Flp-In T-REx (Invitrogen) cells were cultured as monolayers in Dulbecco’s 
modified Eagle’s medium (D-MEM, Gibco) supplemented with 10% foetal bovine serum (FBS; Gibco) 
and antibiotics (Penicicillin-Streptomycin; Sigma-Aldrich) at 37ºC in a 5% CO2 humidified 
atmosphere. The stable HEK293 Flp-In T-REx cell lines obtained in this study using the Flp-In system 
(Invitrogen) were grown in DMEM supplemented with Tet-free FBS (Autogen Bioclear or Invitrogen) 
and hygromycin B (100 g/ml) and blasticidin (10-15 g/ml; both from Invitrogen). Transfections were 
done with either Lipofectamine2000 (Invitrogen) or polyethyleneimine (PEI; Euromedex) according to 
the manufacturers’ guidelines.  
The stable inducible cell lines overexpressing different versions of hDIS3 and hDIS3L as well 
as hRRP6 and hRRP41 were generated with the use of the Flp-In™ T-REx™ system (Invitrogen) 
according to the protocol of the manufacturer.  
RNAi and cell viability assays 
siRNA-mediated knockdown was done essentially as described in (Preker et al, 2008). Briefly, 
6x105 HeLa cells were seeded in 100 mm plates. 24 h later they were transfected with 20 nM siRNA 
using 10 µl SilentFect (BioRad) After 60 h, the cells were re-transfected using 10 µl of 
Lipofectamine2000 (Invitrogen). 48 h later, cells were harvested. siRNA targets are listed in 
Supplementary Table S4. 
5Cell viability was determined by running two depletion experiments in parallel and counting 
cells twice, using a “Countess® Automated Cell Counter” (Invitrogen), 2 or 4 days, respectively, after 
the second transfection. 
Reverse transcription, quantitative PCR and Northern blotting 
1 g of DNaseI-treated RNA extracted from HeLa cells was reverse transcribed by using 20 
pmol of an anchored dT primer (Supplementary Table S4) and Superscript II reverse transcriptase 
(Invitrogen) according to the manufacturer’s instructions in a final volume of 20 µl. 1/40 of a cDNA 
reaction was mixed with Platinum SYBR Green (Invitrogen) and 2x2.5 pmol of oligonucleotides 
(Supplementary Table S4) in a final volume of 20 µl and used for real-time PCR analysis on a 
Mx3005P machine (Stratagene) using an annealing temperature of 59°C. Negative controls lacking 
Superscript II reverse transcriptase showed a negligible background. All data were normalized to 
GAPDH mRNA. 
Northern blotting was done by customary methods. 10 g of total HeLa RNA were separated on 
a 7% denaturing polyacrylamide gel followed by electroblotting onto a Hybond N+ membrane (GE 
Healthcare). Alternatively, 10 g of total yeast RNA were separated on a 1% denaturing agarose gel 
containing 0.925% formaldehyde and immobilized on the same type of membrane by overnight 
capillary transfer in 20xSSC (3 M NaCl, 0,3 M sodium citrate) The blots were handled according to 
standard procedures and probed either at 42˚C with oligonucleotide probes directed against human 5.8S 
rRNA or yeast SRP RNA (scR1) (Supplementary Table S4) or at 65˚C with probes against hDIS3 or 
hDIS3L, generated by digestion of .pHEX18 or pHEX19 plasmid construct with Acc65I/EcoRI or 
Acc65I/HindIII restriction enzymes, respectively. 
Heterologous expression and purification of proteins 
Full-length wild-type yeast Dis3p was purified as described in (Lebreton et al, 2008). For 
purification of full-length and truncated hDIS3 and hDIS3L versions, E. coli BL21-CodonPlus-RIL 
strain (Stratagene) was transformed with appropriate plasmids (pHEX1-pHEX16). Transformants were 
6grown at 37 °C in 1 l of LB medium supplemented with kanamycin (30 g/ml) and chloramphenicol 
(34 g/ml), following inoculation from a pre-culture at OD600 ≈ 0.1. When OD600 reached 0.45–0.5, the 
cultures were cooled to 16 °C for 30 min and protein expression was induced by the addition of 
isopropyl β-D-thiogalactopyranoside (Sigma-Aldrich) to a final concentration of 1 mM. Cultures were 
then incubated overnight at 16 °C. After centrifugation, pellets were resuspended in buffer 1 (20 mM 
Tris-HCl, pH 8.0; 200 mM NaCl; 10 mM imidazole; 10 mM 2-mercaptoethanol) and lysed by 
sonication in a Bioruptor device (Diagenode), followed by ultracentrifugation at 32000 rpm for 45 min 
in a Beckman 35 Ti rotor. Native protein extracts were loaded on an Ni-NTA Superflow Cartridge 1 ml 
column (QIAGEN) compatible with the Äkta FPLC purification system (GE Healthcare). The column 
was washed with buffer 1 and then with buffer 2 (20 mM Tris-HCl, pH 8.0; 1 M NaCl; 10 mM 
imidazole; 10 mM 2-mercaptoethanol). After re-equilibration with buffer 1, proteins bound to the resin 
were eluted using buffer 3 (20 mM Tris-HCl, pH 8.0; 200 mM NaCl; 600 mM imidazole; 10 mM 2-
mercaptoethanol). Fractions of the eluate were combined and dialysed overnight at 4 °C against 2 l of 
buffer 1 in the presence of 6×His-tagged SUMO protease (10 g/ml). After dialysis, the protein mixture 
was subjected to a second round of purification on an Ni-NTA Superflow Cartridge 1 ml column, 
including the collection of purified protein (devoid of 6×His-SUMOTag) in the flowthrough fraction 
(in buffer 1) and elution of 6×His-SUMOTag along with 6×His-SUMO protease in buffer 4 (20 mM 
Tris-HCl, pH 8.0; 1 M NaCl; 600 mM imidazole; 10 mM 2-mercaptoethanol). Proteins were further 
purified by size-exclusion chromatography on either Superdex 200 10/300 GL (for FL and Cterm 
protein versions) or Superdex 75 10/300 GL (for Nterm protein versions) column (GE Healthcare). The 
final elution was always performed using 10 mM Tris-HCl, pH 8.0 with 150 mM NaCl. Finally, 
glycerol was added to the protein preparations (30% final concentration), which were stored at −80 °C. 
The purity of the proteins was assessed by electrophoresis in NuPAGE gels (Invitrogen). 
7Purification of FLAG-tagged proteins from yeast following complementation assays 
Pelleted yeast cells obtained from 4 liters of culture at logarithmic phase (-LEU medium) were 
resuspended in 5 ml of lysis buffer (40 mM Hepes-KOH, pH 8.0; 75 mM NaCl for hDIS3 or 150 mM 
NaCl for hDIS3L; 1 mM DTT) and freezed in liquid nitrogen. Frozen pellets were broken in laboratory 
blender with dry ice for 8 minutes, and subsequently 5 ml of lysis buffer with 2 x protease inhibitors 
coctail. Following ultracentrifugation at 32000 rpm for 90 min in a Beckman 35 Ti rotor lysates were 
dialysed against 2 liters of dialysis buffer (40 mM Hepes-KOH, pH 8.0; 75 mM NaCl for hDIS3 or 150 
mM NaCl for hDIS3L; 1 mM DTT; 1 mM PMSF; 20 M benzamidine hydrochloride; 25% glycerol 
(w/v)) for 3 hours in 4ºC. 14 ml of dialysed protein extract from each strain was obtained. Half of each 
extract (7 ml) was incubated overnight in 4ºC with 150 l of Agarose anti-FLAG (M2) beads (Sigma) 
with rotation. After binding beads were collected and washed twice with 10 ml of LS buffer (10 mM 
Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM DTT; 1 mM PMSF; 1 x protease inhibitors coctail), then with 
10 ml of HS buffer (as LS, but with 1 M NaCl) and again twice with 10 ml of LS buffer. Finally, beads 
with bound proteins were suspended in 50 l of LS buffer, mixed with an equal volume of 2x Laemmli 
buffer (0.125 M Tris-HCl, pH 6.8; 4% SDS; 20% glycerol; 10% 2-mercaptoethanol, 0.004% 
bromphenol blue) and analyzed in SDS-PAGE.  
Purification of TAP-tagged proteins from HEK293 Flp-In T-REx cells for proteomic analyses  
Induced HEK293 Flp-In T-Rex cells were collected by pipetting and washed with PBS. Cell 
pellets were weighed and, assuming a density of 1.25 g/ml, suspended in one pellet volume of buffer 
2xA. Then two pellet volumes of buffer A were added and the cells were disrupted by sonication with a 
Bioruptor device. Disrupted cells were centrifuged at 1600xg for 10 min to discard the cell debris and 
undisrupted cells. The supernatant was collected and ultracentrifuged at 32000 rpm for 40 min in a 
Beckman 35 Ti rotor. The pellet containing the insoluble protein fraction was discarded and the 
supernatant containing soluble fraction was collected. 1/100 volume of 10% Triton X-100 was added 
and the solution was purified on IgG-Sepharose (Amersham Pharmacia). The resin (50 l/g pellet) was 
8placed in a PolyPrep column (Biorad) and equilibrated with buffer A. The protein solution was loaded 
on the column and incubated for 2 h at 4°C with rotation. After binding, the column was drained, 
washed twice with buffer A and twice with buffer B. After draining of the last wash, the resin was 
resuspended in buffer B (200 l/g pellet) and TEV protease was added, followed by incubation at room 
temperature for 2 h. The column was then drained and washed twice with the same volume (i.e. 220 l 
per gram of initial cell pellet) and the eluate was stored. Subsequently, proteins in the eluate were 
precipitated using the PRM reagent (Marshall et al, 1995) and the pellet was subjected to MS analysis 
to identify purified proteins. 
The entire procedure was performed with different NaCl concentrations for the two human 
DIS3 paralogs knowing that binding of hDIS3 to the core is dependent on ionic strength. Thus two 
types of buffer A were used, both containing 10 mM Tris-HCl, pH 8.0; 1 mM DTT; 1 mM PMSF and 
1x protein inhibitor cocktail, with A1 also containing 50 mM NaCl for hDIS3-TAP and A2 – 125 mM 
NaCl for hDIS3L-TAP. Respective buffers B1 and B2 were similar, but with the addition of 0.5 mM 
EDTA. 
Substrate and molecular weight marker preparation for in vitro biochemical assays 
ss17-A14, ss17-A30 and ss44 oligoribonucleotides (Invitrogen) were purified by electrophoresis 
in a 10% polyacrylamide gel containing 8 M urea. Oligoribonucleotides were detected by ultraviolet 
shadowing, excised and the RNAs were eluted overnight at 25oC in a buffer containing 100 mM Tris-
HCl, pH 8.0; 12.5 mM EDTA; 150 mM NaCl; 1% SDS and an equal volume of phenol:chloroform 
(1:1; v:v). 
5′-end labelling of substrates was performed with T4 polynucleotide kinase (NEB) and [γ-
32P]ATP (GE Healthcare) according to the manufacturer’s instructions.  
93′-end labelling was performed with [32P]pCp, either home-made (prepared by incubating 
cytidine 3′-monophosphate with [γ-32P]ATP in the presence of T4 polynucleotide kinase) or purchased 
from Perkin-Elmer, and T4 RNA ligase (NEB), according to the manufacturer’s instructions. 
Circularized ss17-A14 substrate was prepared by incubating 150 pmol of the oligoribonucleotide 
with 250 pmol of unlabelled ATP and 4 pmol of [γ-32P]ATP in a buffer containing 50 mM Tris-HCl, 
pH 8.0; 10 mM MgCl2; 10 mM DTT, in the presence of both T4 polynucleotide kinase and T4 RNA 
ligase. 
All labelled RNA substrates were purified following electrophoresis in 10-20% denaturing 
polyacrylamide gels with 8 M urea as described above. 
3 nt-long molecular weight marker was generated by digestion of 5’-labelled compl 
oligoribonucleotide (see Supplementary Table S4) with RNase T1 (Roche).  
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Supplementary Figure S1. In silico analysis of hDIS3 and hDIS3L amino acid sequence and 1 
evolutionary history. 2 
(A) Full sequence alignment of yeast Dis3p (Dis3p_Sc) and its human (DIS3_Hs, DIS3L_Hs) and 3 
mouse (Dis3_Mm, Dis3l_Mm) counterparts. Conserved amino acid residues are marked in grey. 4 
Positions of functional domains are indicated above the alignment. Residues involved in the 5 
coordination of divalent cations in the catalytic centers of PIN and RNB domains are marked in red and 6 
residues potentially participating in substrate binding are marked in blue. 7 
(B) Paralogy of the Dis3 gene in vertebrates. Maximum likelihood phylogenetic tree of the Dis3 protein 8 
family. 9 
Supplementary Figure S2. Co-purification of exosome components with hDIS3-TAP and 1 
hDIS3L-TAP. MS after purification from cell lines expressing TAP-tagged versions of either hDIS3 or 2 
hDIS3L. Peptides of exosome components identified by MS are highlighted in red. 3 
Supplementary Figure S3. Intracellular localization of FLAG-tagged hDIS3, hDIS3L and hRRP6 1 
in HEK293 Flp-In T-REx cells. Stable lines were treated with tetracycline and subjected to a-FLAG 2 
antibody staining and confocal microscopy. Hoechst stained nuclei were overlayed as indicated. 3 
Supplementary Figure S4. Western blotting analysis of cell extracts from uninduced and Tet-1 
induced hRRP6-FLAG, hDIS3-FLAG, hDIS3L-FLAG and hRRP40-FLAG HEK293 Flp-In T-2 
REx cell lines. 3 
(A) upper panel: the indicated dilutions of extracts were probed with antibodies recognizing 4 
endogenous versions of hRRP6, hDIS3, hDIS3L and hRRP40. The degree of factor overexpression 5 
(indicated on the right) was calculated by quantifying (using Quantity One; BioRad) the average ratio 6 
of the three signals in the Tet-induced extracts (containing both endogenous and FLAG-tagged 7 
proteins) and the three signals in the uninduced extracts (containing endogenous proteins only); lower 8 
panel: similar dilutions of Tet-induced extracts were probed with an á-FLAG antibody. Relative levels 9 
of the four FLAG-tagged exosomal factors (indicated on the right) were calculated by quantifying the 10 
bands’ intensities as above. The separating line between the hRRP40-FLAG and the remaining blots 11 
indicates that these were run in separate gels. 12 
(B) The relative cellular levels of endogenous hRRP6, hDIS3, hDIS3L and hRRP40 were calculated by 13 
dividing the relative level of each FLAG-tagged protein with its overexpression level from (A). 14 
Supplementary Figure S5. Relative amounts of cells at 2 and 4 days after second siRNA 1 
treatment. HeLa cells were plated at 0.5x10
5
 cells/ml in 11ml of DMEM media (without antibiotics). 2 
After 24 h cells were treated with the indicated siRNAs and re-transfected after an additional 60 h. One 3 
set of plates was counted two days after the second siRNA treatment (grey columns), and a second set 4 
of plates was counted after four days (black columns). Standard deviations are shown (n=2). siRNA 5 
targeting an unrelated TEL/AML fusion transcript was used as a negative control (C).  6 
 7 
 8 
Supplementary Figure S6. Purification and biochemical analysis of hDIS3 and hDIS3L protein 1 
variants expressed in E. coli.  2 
 (A) Schematic representations of all expressed proteins: Full-length (FL)-, N-terminal part 3 
encompassing the PIN domain (Nterm)- and C-terminal part corresponding to the RNase II/R-4 
homology region (Cterm)-versions of hDIS3 and hDIS3L in their WT form or containing mutation(s) 5 
within either their RNB (RNB MUT) or PIN (PIN MUT) domain or in both (DM). Positions of 6 
introduced mutations within the catalytic centers of the RNB and PIN domains are indicated by yellow 7 
and orange circles, respectively. Note that as WT hDIS3L lacks a conserved aspartic acid in the 140 8 
position corresponding to D146 in hDIS3, another residue (D62) was mutated to create PIN MUT 9 
versions of the FL and Nterm proteins.  10 
(B) SDS-PAGE analysis of expressed recombinant proteins. hDIS3 and hDIS3L variants were purified 1 
by nickel-column affinity chromatography followed by size exclusion. Protein preparations were 2 
loaded on NuPAGE
®
 gels together with PageRuler
TM 
Prestained Protein Ladder as a molecular weight 3 
marker. Masses of individual bands are indicated on the right. Positions of bands corresponding to the 4 
full length purified proteins are marked with asterisks. Solid arrows indicate degradation products. 5 
Open arrow denotes bacterial DnaK chaperone contamination.  6 
(C and D) Denaturing PAGE and phosphorimaging analysis of products generated after incubation of 7 
5'-labelled ss17-A14 oligoribonucleotide substrate with the indicated hDIS3 variants or no protein as 8 
indicated. Reactions were performed in the presence of 100 ìM magnesium and terminated after the 9 
time points indicated above the lanes.  10 
Supplementary Figure S7. Biochemical analysis of WT and RNB MUT hDIS3 and hDIS3L 1 
variants purified from human cells using FLAG epitope.  2 
(A) SDS-PAGE analysis of hDIS3-FLAG (left) and hDIS3L-FLAG (right) purifications. Bands 3 
corresponding to full length proteins immobilized on anti-FLAG M2 beads are marked with asterisks. 4 
Solid and open arrowheads indicate heavy and light chains of anti-FLAG antibodies coupled to the 5 
resin, respectively. The identity of proteins bound to the beads was revealed by mass-spectrometry 6 
analyses. Column-bound proteins were employed in biochemical experiments shown in (B). Lane 7 
designations: EX – native protein extract; FT – flowthrough; B – anti-FLAG resin with bound proteins; 8 
M – PageRuler
TM 
Prestained Protein Ladder (Fermentas). Molecular masses of the bands are indicated 9 
on the right.  10 












immobilized on anti-FLAG M2 beads or in the absence of added protein. Samples were collected at the 3 
indicated time points and analyzed by denaturing PAGE and phosphorimaging. 4 
Supplementary Figure S8. hDIS3 and hDIS3L release mononucleotide as a major terminal 
degradation product with 3’-labelled substrate. ss17-A14 substrate labelled at the 3’-end with 
[
32





Dis3p or an “empty vector”. Reactions were terminated at the indicated time points followed by 
denaturing PAGE and phosphorimaging. pCp used for the substrate labeling was employed as a 
molecular weight marker. Final hDIS3, hDIS3L and Dis3p protein concentrations were 0.25 ìM, 
0.04 ìM and 0.2 ìM, respectively. 
Supplementary Figure S9. Degradation of different oligonucleotide substrates by hDIS3 PIN 





 or in the absence of protein, in a buffer containing 3 mM 
manganese. Reactions were terminated at the indicated time points followed by denaturing PAGE and 
phosphorimaging. The final hDIS3 protein concentration was 0.25 ìM. 
 
Supplementary Figure S10. hDIS3L PIN domain does not display nucleolytic activity, 





, in various buffers containing magnesium, manganese or zinc 
cations at different concentrations, as indicated. Reactions were terminated at the indicated time 
points followed by denaturing PAGE and phosphorimaging. hDIS3
RNB MUT
 is inactive in all cases, 
while hDIS3
WT 
has only exoribonuclease activity, which is most robust with magnesium as a 
cofactor and inhibited at higher concentrations of divalent cations. The final hDIS3L protein 
concentration was 0.04 ìM. 
Supplementary Figure S11. Complementation of yeast Dis3p by hDIS3 is strictly dependent on its 1 
exonuclease activity. LEU-marked plasmids bearing the indicated mutant versions of hDIS3 or an 2 
empty vector control were transformed into a yeast strain harboring endogenous DIS3 under control of 3 
a doxycycline repressible promoter. Growth phenotypes of the resulting strains were analyzed in the 4 
absence (-LEU, endogenous DIS3 expressed) or presence (-LEU +DOX, endogenous DIS3 repressed) 5 
of doxycycline.  6 
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hRRP42 IPI00014198.2 10 22576 x 21,61 20,7 532 
hCSL4 IPI00032823.1 5 11333 x 21,02 13,6 252 
hRRP41 IPI00745613.1 11 46789 x 20,33 20,9 637 
hRRP4 IPI00304925.5 11 35262 x 19,00 16,7 690 
hRRP45 IPI00029697.3 8 24203 x 18,00 5,7 520 
hMPP6 IPI00016074.1 3 7136 x 14,52 4,2 95 
hRRP40 IPI00015956.3 6 12541 x 14,30 5,6 242 
hMTR4 IPI00647217.2 21 8687 x 13,68 6,8 1103 
hRRP46 IPI00015955.5 6 13776 x 13,56 12,8 270 
hRRP6 IPI00009464.1 20 12195 x 12,10 4,6 944 
hMTR3 IPI00073602.1 4 10712 x 10,13 3,8 170 
hDIS3L IPI00291003.6 1 78 x 9,65 2,1 71 
LOC435309 IPI00036267.3 1 240308 x 8,24 1,8 15 
hRRP43 IPI00552920.2 10 31743 x 7,83 3,5 506 
RPL11 IPI00376798.3 7 53804 x 5,78 10,6 357 
SHMT2 IPI00002520.1 1 290 x 5,38 1,2 46 
JAK1 IPI00784013.1 2 633 x 3,17 3,4 100 
GTPBP4 IPI00385042.4 2 524 x 2,78 0,7 97 
HNRNPU IPI00479217.1 9 10030 x 2,70 4,2 381 
RPL34 IPI00219160.3 4 28773 x 2,54 0,6 128 
RPL30 IPI00219156.7 7 34402 x 2,31 0,6 342 
RPL18A IPI00026202.1 5 9870 x 2,27 0,7 227 
RPL22 IPI00219153.4 2 25177 x 2,15 0,4 131 
RPLP0 IPI00008530.1 1 2700 x 2,15 0,5 38 
RPL32 IPI00395998.5 4 19273 x 2,12 0,5 162 
RPLP1  
ISOFORM 2 
IPI00412779.2 1 49188 x 2,12 0,5 52 
RPL10 IPI00853161.1 6 11832 x 2,11 0,5 219 
RPL10A IPI00412579.6 2 2885 x 2,10 0,5 83 
RPL14 IPI00555744.6 6 21333 x 2,10 0,5 294 
RPL24 IPI00306332.4 3 9934 x 2,09 0,5 141 
RPL27 IPI00219155.5 4 36695 x 2,09 0,5 105 
RPL13A IPI00304612.9 5 19435 x 2,05 0,5 176 
RPL3 IPI00550021.4 15 23109 x 2,04 0,5 596 
RALY IPI00011268.2 3 2588 x 2,03 0,4 110 
RPL28 IPI00182533.5 9 29721 x 1,98 0,5 230 
RPL6 IPI00329389.8 11 24384 x 1,98 0,5 495 
RPLP0  IPI00556485.2 7 19579 x 1,98 0,7 389 
RPLP2 IPI00008529.1 5 61949 x 1,97 0,5 278 
CORO1B IPI00007058.1 1 534 x 1,97 0,4 51 
RPL17 IPI00413324.6 4 11358 x 1,95 0,5 198 
RPL9 IPI00031691.1 4 23447 x 1,94 0,4 198 
RPL15 IPI00470528.5 4 14870 x 1,93 0,5 187 
RPL37A IPI00414860.6 4 10935 x 1,93 0,5 197 
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RPL19 IPI00025329.1 5 9453 x 1,92 0,5 233 
ACTG1 IPI00021440.1 1 13485 x 1,92 0,4 119 
RPL18 IPI00215719.6 6 35049 x 1,91 0,5 305 
RPL7 IPI00030179.3 9 23534 x 1,90 0,5 376 
HSPA8 IPI00003865.1 11 8201 x 1,89 0,5 635 
RPL21 IPI00247583.5 6 17664 x 1,89 0,6 264 
RPL36AL IPI00056494.5 2 8238 x 1,89 0,4 82 
RPL12 IPI00024933.3 5 12167 x 1,87 0,4 258 
RPL7A IPI00299573.12 10 27433 x 1,87 0,5 507 
RPL27A IPI00456758.4 4 29534 x 1,86 0,4 179 
RPL4 IPI00003918.6 13 19973 x 1,86 0,5 521 
HNRPM IPI00171903.2 9 5671 x 1,85 0,5 471 
RPL26 IPI00027270.1 6 17855 x 1,85 0,4 219 
RPLP1 IPI00008527.3 2 19904 x 1,85 0,5 83 
RPL13 IPI00465361.4 7 30794 x 1,83 0,4 314 
RPL38 IPI00215790.6 2 15687 x 1,81 0,4 75 
RPL8 IPI00012772.8 8 11848 x 1,79 0,4 326 
LOC285053 IPI00472864.2 1 1645 x 1,78 0,4 17 
LOC651825 IPI00735961.2 1 12213 x 1,77 0,4 19 
RPL31 IPI00026302.3 5 29330 x 1,75 0,4 185 
RPL5 IPI00000494.6 11 14928 x 1,75 0,8 324 
U2AF1 IPI00005613.3 1 948 x 1,75 0,4 67 
RBM39 IPI00163505.2 1 375 x 1,74 0,4 48 
RPL29 IPI00419919.5 3 7796 x 1,72 0,5 93 
CFL1 IPI00012011.6 7 19722 x 1,72 0,5 331 
RPL23 IPI00010153.5 1 1236 x 1,71 0,4 47 
NPM1 IPI00220740.1 7 8528 x 1,68 0,5 239 
THOC4 IPI00328840.9 1 665 x 1,65 0,4 34 
RPL35A IPI00029731.8 1 1467 x 1,62 0,4 48 
SNRPD2 IPI00017963.1 9 57962 x 1,61 0,4 380 
CSDA IPI00031801.4 1 1465 x 1,59 0,4 99 
SF3B14 IPI00032827.1 3 9560 x 1,59 0,4 230 
RUVBL2 IPI00009104.7 2 442 x 1,57 0,4 95 
SNRPB2 IPI00029267.1 2 1029 x 1,57 0,4 86 
U2AF2 IPI00031556.7 1 438 x 1,57 0,4 45 
HNRNPC IPI00216592.2 8 21397 x 1,55 0,8 436 
CFL2 IPI00413344.3 2 3254 x 1,55 0,4 51 
SLC25A5 IPI00007188.5 3 4578 x 1,52 0,4 153 
SNRPD1 IPI00302850.4 4 57377 x 1,52 0,4 253 
EIF3D IPI00006181.1 5 3543 x 1,51 0,8 150 
RBM17 IPI00176706.1 3 1643 x 1,50 0,4 146 
SF3A3 IPI00029764.1 8 4347 x 1,48 0,5 427 
ARPC5L IPI00414554.5 1 1660 x 1,47 0,3 66 
BAT2 IPI00010700.2 2 180 x 1,47 0,5 80 
CORO1C IPI00867509.1 22 43301 x 1,47 0,4 1188 
SF3A1 IPI00017451.1 7 2457 x 1,46 0,4 264 
RPS24 IPI00219486.2 4 33802 x 1,45 0,4 223 
RPS29 IPI00182289.6 1 20516 x 1,45 0,3 48 
STK38 IPI00027251.1 22 49188 x 1,45 0,4 1105 
XRCC5 IPI00220834.8 1 315 x 1,45 0,3 50 
RPS8 IPI00216587.9 12 47838 x 1,44 0,5 678 
ACTB IPI00021439.1 23 497776 x 1,44 0,4 1577 
RPS25 IPI00012750.3 6 93908 (x) 1,43 0,3 261 
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CALM3 IPI00075248.11 3 17054 (x) 1,43 0,4 152 
RPS12 IPI00847579.1 6 42605 (x) 1,42 0,3 441 
BAT2D1 IPI00083708.2 1 38 (x) 1,42 0,3 24 
TWF1 IPI00183508.3 5 2804 (x) 1,42 0,4 270 
RPS23 IPI00218606.7 5 44317 (x) 1,42 0,3 230 
RPL23A IPI00021266.1 4 24446 (x) 1,41 0,8 195 
TUBB IPI00011654.2 9 4543 (x) 1,41 0,4 410 
TMOD3 IPI00005087.1 7 10060 (x) 1,41 0,4 406 
RPS15A IPI00221091.9 4 23064 (x) 1,40 0,3 167 
DHX9 IPI00844578.1 9 1611 (x) 1,40 0,4 363 
RPS9 IPI00221088.5 14 45194 (x) 1,40 0,6 530 
HSPA1A IPI00304925.5 21 27223 (x) 1,39 0,3 1124 
EIF3F IPI00654777.2 7 9058 (x) 1,38 0,3 434 
RPS19 IPI00215780.5 8 68652 (x) 1,38 0,3 386 
DDX21 IPI00477179.1 5 1467 (x) 1,37 0,3 182 
RPS16 IPI00221092.8 9 62402 (x) 1,37 0,4 397 
RPS6 IPI00021840.1 7 19183 (x) 1,37 0,4 227 
RPS21 IPI00017448.1 6 55930 (x) 1,36 0,3 339 
TUBA1C IPI00166768.3 4 4717 (x) 1,36 0,4 273 
RPS18 IPI00013296.3 13 76080 (x) 1,36 0,3 553 
DHX15 IPI00396435.3 9 4361 (x) 1,35 0,3 498 
RPS13 IPI00221089.5 6 27232 (x) 1,35 0,3 240 
RPS17 IPI00221093.7 7 31363 (x) 1,35 0,4 283 
CAPZB IPI00642256.2 7 9489 (x) 1,34 0,3 291 
SPTAN1 IPI00744706.2 27 2260 (x) 1,34 0,7 1334 
EIF3H IPI00647650.3 5 4064 (x) 1,34 0,3 255 
ARPC5 IPI00007280.9 1 1910 (x) 1,33 0,3 66 
RPS3A IPI00419880.6 15 27652 (x) 1,33 0,3 520 
EIF3B IPI00396370.5 13 6703 (x) 1,33 0,3 706 
AMD1 IPI00016708.2 1 310 (x) 1,33 0,3 41 
ARPC2 IPI00005161.3 2 1705 (x) 1,33 0,3 67 
GNB2L1 IPI00641950.3 12 19359 (x) 1,33 0,3 681 
RPSA IPI00413108.4 13 54686 (x) 1,32 0,3 659 
SF3B3 IPI00300371.5 19 3999 (x) 1,32 0,3 971 
ACTA1 IPI00021428.1 1 1367 (x) 1,31 0,3 59 
SF3B1 IPI00026089.3 17 3696 (x) 1,31 0,4 892 
EIF3EIP IPI00465233.1 13 5631 (x) 1,31 0,3 620 
PSMA4 IPI00299155.5 1 798 (x) 1,30 0,3 54 
RPS20 IPI00012493.1 5 22671 (x) 1,29 0,1 171 
ILF3 IPI00298788.4 2 536 (x) 1,29 0,3 73 
EIF3E IPI00013068.1 5 2350 (x) 1,29 0,3 151 
SNFPF IPI00220528.6 1 3590 (x) 1,29 0,3 90 
RPS3 IPI00011253.3 17 55517 (x) 1,28 0,3 713 
SR140 IPI00143753.6 9 2304 (x) 1,28 0,3 449 
RPS11 IPI00025091.3 10 26386 (x) 1,28 0,4 337 
XRCC6 IPI00644712.4 2 650 (x) 1,28 0,3 135 
SF3B4 IPI00017339.1 2 1884 (x) 1,28 0,3 145 
EIF3C IPI00016910.1 10 3840 (x) 1,28 0,3 579 
SF3B2 IPI00221106.5 12 3791 (x) 1,27 0,4 380 
EIF3I IPI00012795.3 6 6778 (x) 1,26 0,3 267 
EIF3K IPI00033143.1 3 4599 (x) 1,26 0,3 145 
RBM10 IPI00375731.1 40 59627 (x) 1,26 0,3 2059 
RPS5 IPI00008433.4 4 15402 (x) 1,26 0,3 214 
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RPS27A IPI00179330.6 1 2985 (x) 1,25 0,3 21 
CMBL IPI00383046.3 2 830 (x) 1,25 0,3 68 
RPS26L IPI00186712.5 6 37258 (x) 1,25 0,5 237 
RPS4X IPI00217030.10 16 38106 (x) 1,25 0,4 813 
RPS10 IPI00008438.1 7 31655 (x) 1,25 0,4 372 
EIF3A IPI00029012.1 25 3916 (x) 1,24 0,3 907 
EIF3M IPI00102069.5 6 3282 (x) 1,24 0,3 211 
LARP1 IPI00185919.3 2 223 (x) 1,24 0,3 76 
BMS1 IPI00006099.1 7 724 (x) 1,24 0,4 374 
LIMA1 IPI00008918.1 11 5363 (x) 1,24 0,3 638 
EEF1AL3 IPI00472724.1 7 5364 (x) 1,23 0,5 252 
SNRPE IPI00029266.1 1 7352 (x) 1,22 0,3 60 
CALR IPI00020599.1 1 637 (x) 1,21 0,3 86 
STK38L IPI00237011.5 8 9787 (x) 1,20 0,3 334 
EIF3G IPI00290460.3 8 6043 (x) 1,19 0,3 316 
RPS7 IPI00013415.1 3 18713 (x) 1,19 0,3 124 
SPTBN1 IPI00005614.6 22 1630 (x) 1,19 0,3 1000 
SNRPD3 IPI00017964.1 7 97682 (x) 1,18 0,8 406 
SPIN1 IPI00550655.4 8 9654 (x) 1,18 0,3 360 
RPS14 IPI00026271.5 5 25835 (x) 1,17 0,3 243 
DDX3X IPI00215637.5 1 116 (x) 1,16 0,3 55 
RPS15 IPI00216153.7 4 5235 (x) 1,15 0,3 166 
PRPF19 IPI00004968.1 2 965 (x) 1,15 0,3 69 
HSPA5 IPI00003362.2 13 4327 (x) 1,14 0,4 653 
HSP90AB1 IPI00414676.6 4 1215 (x) 1,14 0,3 172 
NAP1L1 IPI00023860.1 4 2974 (x) 1,13 0,3 188 
EPB41L3 IPI00032230.2 9 1546 (x) 1,12 0,3 470 
ASCC3L1 IPI00420014.2 12 948 (x) 1,12 0,3 510 
PRPF31 IPI00292000.6 18 20971 (x) 1,11 0,3 922 
EFTUD2 IPI00003519.1 10 2044 (x) 1,11 0,3 489 
HIST1H4H IPI00453473.6 7 33126 (x) 1,11 0,3 374 
PRPF8 IPI00007928.4 8 577 (x) 1,09 0,3 301 
P4HB IPI00010796.1 6 2266 (x) 1,08 0,3 262 
EIF4B IPI00012079.1 37 46260 (x) 1,07 0,3 1554 
MYO5B IPI00479962.4 4 163 (x) 1,06 0,4 184 
TPP2 IPI00020416.8 1 99 (x) 1,06 0,2 94 
HIST1H2BL IPI00018534.4 4 32765 (x) 1,02 0,3 160 
EIF3J IPI00290461.3 3 1984 (x) 0,99 0,3 106 
RCL1 IPI00642256.2 1 415 (x) 0,99 0,3 42 
CLNS1A IPI00004795.1 8 91351 (x) 0,99 0,3 587 
HIST1H2AE IPI00026272.2 3 14143 (x) 0,96 0,2 100 
VIM IPI00418471.6 36 60441 (x) 0,94 0,2 1802 
WDR77 IPI00647794.2 14 277402 (x) 0,94 0,3 990 
RNPS1 IPI00033561.3 2 1430 (x) 0,94 0,3 107 
HIST2H3C IPI00171611.7 1 1596 (x) 0,91 0,2 22 
PPIA IPI00419585.9 1 356 (x) 0,91 0,2 36 
RIOK1 IPI00171336.3 17 10485 (x) 0,90 0,2 874 
MIF IPI00293276.10 1 1080 (x) 0,89 0,2 37 
ROCK1 IPI00022542.1 2 112 (x) 0,88 0,4 84 
SNRPB IPI00027285.1 8 41453 (x) 0,85 0,3 394 
PRMT5 IPI00441473.3 44 322281 (x) 0,83 0,2 2577 
PRPSAP2 IPI00003168.1 12 8992 (x) 0,82 0,2 595 
BOLA2B IPI00410226.3 3 16554 (x) 0,80 0,2 198 
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FLNA IPI00302592.2 8 355 (x) 0,77 0,3 415 
MYO1C IPI00010418.4 2 213 (x) 0,77 0,2 137 
KIF11 IPI00305289.2 37 10343 (x) 0,56 0,1 2021 
GSN IPI00026314.1 7 734 (x) 0,39 0,1 324 
IGHG1 IPI00470657.1 5 955 (x) 0,16 0,2 256 
x: Indicates that the protein is found in the experiment with a SILAC ratio above background.(x): Indicates that the protein is found in 
the experiment, but with a SILAC ratio below background.  
To be able to compare protein intensities, the intensities are normalized to protein size (MW), since a large protein will contain more 
Arg or Lys containing peptides, than a smaller. The protein intensity/MW is calculated by summing the intensity of the heavy labelled 
peptides originating from a specific protein, and dividing this value with the molecular weight.  
Proteins with a SILAC ratio above 1 + 2 x average standard dev (for all proteins identified in this experiment) are believed to be true 
interaction partners. 
The "Protein score" is the summed peptide scores for a given protein 
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DDEFL1 IPI00152667.3 1 304 x 100,50 52 4 
hRRP44 IPI00746351.2 20 2014 x 31,59 16,35 858 
hRRP45 IPI00029697.3 2 136 x 5,85 3,03 101 
hRRP46 IPI00644775.1 3 240 x 5,64 2,92 74 
hCSL4 IPI00032823.1 3 242 x 5,37 2,78 74 
hRRP4 IPI00015905.1 4 293 x 5,23 2,71 80 
hRRP41 IPI00745613.2 1 62 x 5,16 2,67 30 
hRRP6 IPI00009464.1 6 133 x 4,65 2,41 216 
hRRP42 IPI00014198.2 3 117 x 4,56 2,36 159 
hRRP43 IPI00552920.2 2 58 x 2,98 1,54 38 
hMTR4 IPI00647217.2 10 159 x 2,93 1,52 326 
STUB1 IPI00025156.4 1 18 x 2,11 1,09 84 
ITM2B IPI00031821.1 1 86 x 2,05 1,06 58 
HSPA8 IPI00003865.1 33 3205 (x) 1,65 0,85 1396 
PSMA4 IPI00299155.5 1 38 (x) 1,57 0,81 59 
HSPA1A IPI00304925.5 30 4539 (x) 1,51 0,78 1269 
SLC25A5 IPI00007188.5 7 650 (x) 1,39 0,72 309 
STK38 IPI00027251.1 11 644 (x) 1,32 0,69 373 
EIF4G1 IPI00384463.3 7 79 (x) 1,29 0,68 280 
LARP1 IPI00185919.3 7 41 (x) 1,29 0,67 294 
TUBB IPI00011654.2 11 608 (x) 1,26 0,66 508 
RPL30 IPI00219156.7 5 2071 (x) 1,23 0,64 204 
RPL14 IPI00555744.6 8 1695 (x) 1,23 0,66 339 
RPS27A IPI00179330.6 2 304 (x) 1,22 0,67 56 
EIF3M IPI00102069.5 22 882 (x) 1,22 0,66 863 
RPL24 IPI00306332.4 7 2411 (x) 1,19 0,66 322 
HNRPF IPI00003881.5 3 115 (x) 1,17 0,66 135 
RUVBL2 IPI00009104.7 4 106 (x) 1,16 0,61 208 
RPS15A IPI00221091.9 9 4575 (x) 1,15 0,7 314 
RUVBL1 IPI00021187.4 3 72 (x) 1,15 0,7 132 
RPL9 IPI00031691.1 5 3108 (x) 1,15 0,81 168 
HSPA5 IPI00003362.2 11 291 (x) 1,15 0,62 519 
RPS21 IPI00017448.1 19 16159 (x) 1,15 0,65 822 
SERBP1 IPI00410693.3 2 213 (x) 1,15 0,8 48 
CFL1 IPI00012011.6 11 2433 (x) 1,15 0,7 427 
ACTA1 IPI00021428.1 7 2602 (x) 1,14 0,72 141 
EIF3E  IPI00013068.1 15 1350 (x) 1,14 0,66 701 
RPSA IPI00413108.4 25 7115 (x) 1,13 0,65 803 
EIF3EIP IPI00465233.1 26 1467 (x) 1,13 0,64 864 
ACTB IPI00021439.1 46 17 (x) 1,13 0,67 1876 
RPS11 IPI00025091.3 10 4289 (x) 1,13 0,65 315 
RPS17 IPI00221093.7 8 2797 (x) 1,13 0,83 280 
RPS29 IPI00182289.6 2 3466 (x) 1,13 0,76 84 
RPL5 IPI00000494.6 19 2567 (x) 1,13 0,65 682 
RPL11 IPI00376798.3 6 1601 (x) 1,13 0,67 211 
EIF3C IPI00016910.1 37 1738 (x) 1,13 0,68 1274 
RPS3A IPI00419880.6 23 5855 (x) 1,13 0,61 894 
RPL34 IPI00219160.3 5 1810 (x) 1,12 0,7 117 
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RPS12 IPI00847579.1 8 6167 (x) 1,12 0,62 262 
EIF4A1 IPI00025491.1 17 1406 (x) 1,12 0,71 883 
EIF3H IPI00647650.3 24 2293 (x) 1,12 0,74 986 
RPL15 IPI00470528.5 8 652 (x) 1,12 0,72 199 
RPL13A IPI00304612.9 14 3055 (x) 1,12 0,62 362 
TUBA1C IPI00166768.3 7 627 (x) 1,11 0,61 261 
RPS10 IPI00008438.1 6 1944 (x) 1,11 0,79 216 
SNRPB2 IPI00029267.1 5 832 (x) 1,11 0,71 163 
GNB2L1 IPI00641950.3 22 6213 (x) 1,11 0,64 828 
RPLP2 IPI00008529.1 15 18245 (x) 1,11 0,82 808 
EIF3I IPI00012795.3 16 1972 (x) 1,10 0,62 446 
EIF3B IPI00396370.5 32 1595 (x) 1,09 0,74 1184 
HNRNPC IPI00216592.2 22 5707 (x) 1,09 0,74 1057 
SPTBN1 IPI00005614.6 25 182 (x) 1,09 0,72 826 
RPL7 IPI00030179.3 11 1550 (x) 1,08 0,96 400 
TPP2 IPI00020416.8 36 716 (x) 1,08 0,71 1379 
RPL31 IPI00026302.3 11 6033 (x) 1,08 0,78 257 
RPL12 IPI00024933.3 7 2231 (x) 1,08 0,78 256 
RPS6 IPI00021840.1 13 3194 (x) 1,08 0,82 482 
HNRPM IPI00171903.2 14 264 (x) 1,07 0,83 519 
EIF3A IPI00029012.1 54 1609 (x) 1,07 0,7 1846 
RPS9 IPI00221088.5 21 3694 (x) 1,07 0,69 621 
RPS8 IPI00216587.9 13 4983 (x) 1,07 0,93 477 
RBM17 IPI00176706.1 13 1012 (x) 1,07 0,89 459 
RPL4 IPI00003918.6 24 2434 (x) 1,06 0,87 777 
RPL26L1 IPI00007144.1 16 2784 (x) 1,06 0,82 510 
RPS19 IPI00215780.5 24 8935 (x) 1,06 0,76 913 
NAP1L1 IPI00023860.1 5 512 (x) 1,06 0,92 209 
VIM IPI00418471.6 28 3464 (x) 1,06 0,7 921 
RPS23 IPI00218606.7 7 2587 (x) 1,06 0,89 250 
RPL27A IPI00456758.4 7 2601 (x) 1,05 0,75 276 
CALM3 IPI00075248.11 3 1316 (x) 1,05 0,92 172 
SPTAN1 IPI00744706.2 30 238 (x) 1,05 0,75 1012 
SR140 IPI00143753.6 12 280 (x) 1,05 0,92 570 
RPL23 IPI00010153.5 3 432 (x) 1,05 0,59 110 
RPS4X IPI00217030.10 22 2784 (x) 1,04 0,71 632 
RPLP0 IPI00008530.1 14 2303 (x) 1,04 0,88 493 
SF3A1 IPI00017451.1 18 613 (x) 1,04 0,77 547 
RPS16 IPI00221092.8 13 3641 (x) 1,04 0,69 425 
ROCK1 IPI00022542.1 18 261 (x) 1,04 0,78 597 
SF3A3 IPI00029764.1 14 947 (x) 1,04 0,72 460 
RPL7A IPI00299573.12 13 2114 (x) 1,04 0,83 405 
EIF3F IPI00654777.2 10 1051 (x) 1,04 0,91 453 
RBM10 IPI00375731.1 34 1608 (x) 1,04 0,82 1257 
RPS2 IPI00013485.3 16 2688 (x) 1,04 0,92 463 
RPL22 IPI00219153.4 8 2778 (x) 1,03 0,63 366 
RIOK1 IPI00171336.3 14 853 (x) 1,03 0,91 541 
PRPF31 IPI00292000.6 19 1066 (x) 1,03 0,87 505 
ASCC3L1 IPI00420014.2 23 128 (x) 1,02 0,95 883 
RPLP1 IPI00008527.3 2 2381 (x) 1,02 0,79 80 
CCAR1 IPI00217357.2 22 406 (x) 1,02 0,86 699 
RPS5 IPI00008433.4 6 1027 (x) 1,02 0,87 321 
RPS18 IPI00013296.3 15 2870 (x) 1,02 0,82 470 
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SNRPD3 IPI00017964.1 8 5215 (x) 1,02 0,93 230 
RPL3 IPI00550021.4 23 1720 (x) 1,02 0,72 740 
SF3B14 IPI00032827.1 5 974 (x) 1,02 0,86 243 
RBBP4 IPI00328319.8 6 305 (x) 1,01 0,84 210 
RPL27 IPI00219155.5 10 2137 (x) 1,01 0,9 199 
SNRPD1 IPI00302850.4 7 1645 (x) 1,01 0,87 301 
THOC4 IPI00328840.9 3 330 (x) 1,01 0,89 78 
EIF3G IPI00290460.3 12 927 (x) 1,01 0,76 398 
SF3B3 IPI00300371.5 25 384 (x) 1,01 0,95 880 
PABPC1 IPI00008524.1 13 272 (x) 1,01 0,93 379 
RPL19 IPI00025329.1 15 2230 (x) 1,01 0,67 437 
RPS13 IPI00221089.5 12 3458 (x) 1,01 0,89 225 
DHX9 IPI00844578.1 10 126 (x) 1,00 0,94 343 
PRPF19 IPI00004968.1 5 160 (x) 1,00 0,95 141 
RPL23A IPI00021266.1 9 1766 (x) 1,00 0,88 414 
SF3B2 IPI00221106.5 30 1172 (x) 1,00 0,87 898 
HNRNPU IPI00479217.1 17 830 (x) 1,00 0,88 622 
RPS25 IPI00012750.3 5 2730 (x) 0,99 0,72 218 
RPS3 IPI00011253.3 23 4672 (x) 0,99 0,9 765 
RPL13 IPI00465361.4 16 2355 (x) 0,99 0,74 448 
RPL32 IPI00395998.5 12 3122 (x) 0,99 0,91 362 
SPIN1 IPI00550655.4 6 418 (x) 0,99 0,89 192 
EFTUD2 IPI00003519.1 28 593 (x) 0,99 0,9 1031 
XRCC6 IPI00644712.4 13 271 (x) 0,98 0,92 443 
PRPF8 IPI00007928.4 29 136 (x) 0,98 0,93 1048 
RPL18 IPI00215719.6 11 2215 (x) 0,98 0,88 340 
RAN IPI00643041.3 1 23 (x) 0,98 0,8 15 
CLNS1A IPI00004795.1 4 676 (x) 0,98 0,85 229 
RPS20 IPI00012493.1 15 4803 (x) 0,97 0,93 459 
RPL10A IPI00412579.6 10 1232 (x) 0,97 0,84 258 
RPS7 IPI00013415.1 23 5312 (x) 0,97 0,89 805 
DDX21 IPI00477179.1 9 205 (x) 0,96 0,66 274 
SF3A2 IPI00017341.3 8 429 (x) 0,96 0,93 211 
MATR3 IPI00017297.1 7 107 (x) 0,96 0,79 171 
HIST1H4H IPI00453473.6 9 3059 (x) 0,96 0,8 365 
RPS28 IPI00719622.1 5 6830 (x) 0,95 0,92 133 
ILF3 IPI00298788.4 11 341 (x) 0,95 0,73 444 
STK38L IPI00237011.5 12 45 (x) 0,95 0,76 407 
SF3B4 IPI00017339.1 8 312 (x) 0,94 0,81 315 
SF3B1 IPI00026089.3 30 623 (x) 0,94 0,9 811 
DHX15 IPI00396435.3 13 245 (x) 0,94 0,86 529 
RPL6 IPI00329389.8 14 1641 (x) 0,93 0,89 432 
EEF1AL3 IPI00472724.1 18 1584 (x) 0,93 0,71 529 
RPS14 IPI00026271.5 7 1742 (x) 0,92 0,75 174 
PRMT5 IPI00441473.3 70 7636 (x) 0,92 0,72 2225 
YWHAE IPI00000816.1 4 139 (x) 0,91 0,66 155 
KIF11 IPI00305289.2 16 239 (x) 0,90 0,6 696 
ATP5B IPI00303476.1 4 27 (x) 0,87 0,56 143 
EPB41L3 IPI00032230.2 12 140 (x) 0,86 0,55 454 
SNFPF IPI00220528.6 2 377 (x) 0,85 0,5 47 
CCT8 IPI00302925.4 14 307 (x) 0,84 0,52 472 
NPM1 IPI00220740.1 13 947 (x) 0,82 0,51 426 
HIST2H3C IPI00171611.7 1 17 (x) 0,82 0,52 37 
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BOLA2B IPI00410226.3 5 708 (x) 0,82 0,48 129 
CCT2 IPI00297779.7 13 363 (x) 0,81 0,47 460 
PRPSAP2 IPI00003168.1 3 40 (x) 0,80 0,45 88 
SNRPD2 IPI00017963.1 8 2183 (x) 0,78 0,54 267 
MAP1B IPI00008868.3 9 27 (x) 0,73 0,39 414 
SNRPB IPI00027285.1 11 870 (x) 0,73 0,45 206 
FLNA IPI00302592.2 19 87 (x) 0,72 0,38 645 
HIST1H2BL IPI00018534.4 12 1685 (x) 0,69 0,36 422 
VCP IPI00022774.3 17 312 (x) 0,68 0,35 579 
DCD IPI00027547.2 1 15 (x) 0,36 0,19 6 
HIST2H2AA3 IPI00216457.7 8 17 (x) 0,24 0,12 288 
x: Indicates that the protein is found in the experiment with a SILAC ratio above background.(x): Indicates that the protein is found in 
the experiment, but with a SILAC ratio below background. 
To be able to compare protein intensities, the intensities are normalized to protein size (MW), since a large protein will contain more 
Arg or Lys containing peptides, than a smaller. The protein intensity/MW is calculated by summing the intensity of the heavy labelled 
peptides originating from a specific protein, and dividing this value with the molecular weight. 
Proteins with a SILAC ratio above 1 + 2 x average standard dev (for all proteins identified in this experiment) are believed to be true 
interaction partners. 
The "Protein score" is the summed peptide scores for a given protein 
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CDYL IPI00293963.4 1 1157 x 253,27 162,42 3 
PICALM REV_IPI00216184.3 1 1134 x 253,27 162,42 1 
DCD REV_IPI00847892.1 1 6291 x 253,27 162,42 4 
FECH IPI00554589.3 1 51 x 110,48 70,85 9 
GIGYF2 IPI00647635.3 12 163 x 11,64 7,46 389 
ZNF598 IPI00328737.2 2 6 x 11,61 7,44 25 
GRID2 IPI00747494.1 1 4 x 9,48 6,08 13 
hDIS3L IPI00879677.1 40 1723 x 9,02 5,79 1419 
EIF4E2 IPI00744211.2 2 57 x 7,33 4,7 62 
hRRP41 IPI00745613.2 1 99 x 6,96 4,46 22 
hRRP46 IPI00644775.1 8 919 x 6,82 4,38 260 
SIPA1L3 IPI00297254.4 1 2 x 6,74 4,32 4 
hRRP6 IPI00009464.1 6 81 x 6,74 4,32 220 
hRRP45 IPI00029697.3 8 433 x 6,68 4,29 340 
hRRP42 IPI00014198.2 7 407 x 6,32 4,06 216 
hRRP4 IPI00015905.1 9 568 x 5,96 3,82 328 
hRRP40 IPI00015956.3 5 332 x 5,90 3,78 267 
hMTR3 IPI00073602.1 1 310 x 5,70 3,65 54 
hCSL4 IPI00032823.1 5 504 x 5,31 3,41 148 
hRRP43 IPI00552920.2 2 129 x 4,96 3,18 61 
hMTR4 IPI00647217.2 6 36 x 4,83 3,1 174 
HBS1L IPI00168609.1 3 28 x 2,33 1,49 117 
DCD IPI00027547.2 1 39 (x) 1,75 1,12 14 
HSPA1A IPI00304925.5 38 2283 (x) 1,69 1,08 1522 
hRRP4 IPI00015905.1 9 4864 (x) 1,69 3,82 328 
HSPA8 IPI00003865.1 33 1564 (x) 1,60 1,03 1358 
EIF3E  IPI00013068.1 17 645 (x) 1,59 1,02 687 
EIF3I IPI00012795.3 14 579 (x) 1,59 1,02 451 
EIF3C IPI00016910.1 27 868 (x) 1,58 1,01 899 
EIF3H IPI00647650.3 23 1164 (x) 1,57 1,01 915 
HNRPM IPI00171903.2 10 84 (x) 1,54 0,99 367 
EIF3EIP IPI00465233.1 23 565 (x) 1,51 0,97 812 
EIF3M IPI00102069.5 17 141 (x) 1,50 0,97 575 
RPS12 IPI00847579.1 7 3515 (x) 1,48 0,98 324 
EIF3F IPI00654777.2 9 270 (x) 1,48 0,97 299 
EIF3B IPI00396370.5 32 649 (x) 1,46 0,95 1048 
EIF3A IPI00029012.1 52 885 (x) 1,46 0,94 1683 
RPS5 IPI00008433.4 4 422 (x) 1,44 0,95 230 
RPS11 IPI00025091.3 9 2973 (x) 1,41 0,93 264 
RPS10 IPI00008438.1 5 693 (x) 1,39 0,91 147 
RPL30 IPI00219156.7 5 735 (x) 1,39 0,9 165 
HNRPF IPI00003881.5 1 5 (x) 1,36 0,9 64 
RPS3A IPI00419880.6 20 3484 (x) 1,36 0,9 581 
RPS19 IPI00215780.5 17 3573 (x) 1,35 0,88 584 
SLC25A5 IPI00007188.5 5 230 (x) 1,34 0,94 248 
HNRNPC IPI00216592.2 19 1486 (x) 1,34 0,88 861 
RPS29 IPI00182289.6 2 1377 (x) 1,33 0,92 77 
RPL24 IPI00306332.4 8 1048 (x) 1,32 0,9 390 
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RPL34 IPI00219160.3 5 892 (x) 1,31 0,88 116 
RPS18 IPI00013296.3 12 2347 (x) 1,31 0,89 408 
RPL27 IPI00219155.5 8 1475 (x) 1,30 0,85 169 
RPS25 IPI00012750.3 5 2301 (x) 1,29 0,86 225 
GNB2L1 IPI00641950.3 18 1454 (x) 1,29 0,9 838 
EIF4A1 IPI00025491.1 13 235 (x) 1,28 0,84 683 
RPS17 IPI00221093.7 6 507 (x) 1,28 0,91 139 
RPS23 IPI00218606.7 6 1835 (x) 1,28 0,98 214 
RPS8 IPI00216587.9 10 2328 (x) 1,28 0,85 392 
RPSA IPI00413108.4 18 1530 (x) 1,28 0,88 797 
RPS21 IPI00017448.1 18 5784 (x) 1,28 0,88 704 
EIF3G IPI00290460.3 7 692 (x) 1,27 0,85 219 
RPL23 IPI00010153.5 3 163 (x) 1,27 0,86 88 
SERBP1 IPI00410693.3 4 111 (x) 1,26 0,96 133 
RPS27A IPI00179330.6 4 355 (x) 1,26 0,85 114 
RPL10A IPI00412579.6 6 504 (x) 1,26 0,91 178 
RPS9 IPI00221088.5 11 626 (x) 1,26 0,85 409 
RPS4X IPI00217030.10 16 968 (x) 1,25 0,88 581 
RPL14 IPI00555744.6 10 676 (x) 1,24 0,9 329 
RPS6 IPI00021840.1 16 2338 (x) 1,24 0,85 432 
RPS16 IPI00221092.8 13 2011 (x) 1,24 0,84 418 
RPS2 IPI00013485.3 11 986 (x) 1,23 0,85 322 
RPS7 IPI00013415.1 14 2000 (x) 1,23 0,86 456 
RPLP2 IPI00008529.1 13 4370 (x) 1,23 0,87 614 
RPS15A IPI00221091.9 5 1007 (x) 1,22 0,86 123 
RPL22 IPI00219153.4 7 628 (x) 1,22 0,87 275 
RPS20 IPI00012493.1 8 1484 (x) 1,22 0,87 198 
SPIN1 IPI00550655.4 5 199 (x) 1,19 0,95 158 
YWHAE IPI00000816.1 2 41 (x) 1,19 0,89 75 
RPL31 IPI00026302.3 7 1491 (x) 1,19 0,87 169 
RBM17 IPI00176706.1 12 537 (x) 1,18 0,91 485 
RPS3 IPI00011253.3 17 1152 (x) 1,18 0,89 523 
RPL11 IPI00376798.3 6 1000 (x) 1,18 1,01 244 
SR140 IPI00143753.6 13 166 (x) 1,18 0,93 515 
RPS14 IPI00026271.5 4 389 (x) 1,18 0,88 127 
RPL3 IPI00550021.4 24 1192 (x) 1,18 0,91 549 
SNRPD3 IPI00017964.1 8 2071 (x) 1,15 0,94 280 
EIF4G1 IPI00384463.3 4 7 (x) 1,15 0,91 77 
STK38 IPI00027251.1 11 266 (x) 1,14 0,85 313 
RPL18 IPI00215719.6 4 574 (x) 1,14 1,03 224 
RPS28 IPI00719622.1 6 3818 (x) 1,13 0,79 132 
RPL26L1 IPI00007144.1 9 1700 (x) 1,13 1,01 257 
RPL5 IPI00000494.6 16 1400 (x) 1,13 0,81 556 
RPL6 IPI00329389.8 11 1094 (x) 1,13 0,89 340 
BOLA2B IPI00410226.3 10 3640 (x) 1,13 0,85 261 
RUVBL1 IPI00021187.4 6 73 (x) 1,13 1,01 192 
RPL19 IPI00025329.1 9 642 (x) 1,12 0,85 293 
HNRNPU IPI00479217.1 12 270 (x) 1,12 1,06 411 
RPLP0 IPI00008530.1 15 675 (x) 1,12 0,91 500 
SF3A1 IPI00017451.1 23 360 (x) 1,11 1,06 590 
RPL12 IPI00024933.3 10 915 (x) 1,11 0,99 347 
RPL23A IPI00021266.1 7 739 (x) 1,10 0,97 253 
MAP1B IPI00008868.3 16 36 (x) 1,10 1,02 774 
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RPL13A IPI00304612.9 7 687 (x) 1,10 0,97 182 
RUVBL2 IPI00009104.7 4 31 (x) 1,10 0,99 215 
RPL4 IPI00003918.6 19 1005 (x) 1,09 1,05 553 
RPL7A IPI00299573.12 13 609 (x) 1,09 1 288 
RBM10 IPI00375731.1 40 929 (x) 1,09 0,87 1512 
TUBB IPI00011654.2 14 105 (x) 1,08 0,94 440 
RPL27A IPI00456758.4 6 657 (x) 1,08 0,89 231 
THOC4 IPI00328840.9 5 175 (x) 1,08 1,05 143 
CCT8 IPI00302925.4 10 89 (x) 1,07 0,99 329 
RPS13 IPI00221089.5 9 877 (x) 1,07 0,93 292 
SPTAN1 IPI00744706.2 39 105 (x) 1,07 1,01 990 
RPL15 IPI00470528.5 8 550 (x) 1,07 0,99 207 
CCT2 IPI00297779.7 12 133 (x) 1,07 0,93 411 
SF3A2 IPI00017341.3 6 127 (x) 1,07 0,9 87 
DDX21 IPI00477179.1 5 46 (x) 1,06 0,99 121 
SPTBN1 IPI00005614.6 26 72 (x) 1,06 1,03 830 
NAP1L1 IPI00023860.1 4 121 (x) 1,05 0,94 192 
SF3B14 IPI00032827.1 4 154 (x) 1,04 0,97 160 
XRCC6 IPI00644712.4 11 52 (x) 1,04 1,02 322 
RPL7 IPI00030179.3 10 555 (x) 1,03 1,03 330 
RPL13 IPI00465361.4 19 1197 (x) 1,03 0,89 499 
PRPF31 IPI00292000.6 16 289 (x) 1,03 1,03 456 
SNRPB2 IPI00029267.1 5 229 (x) 1,03 1,01 131 
RIOK1 IPI00171336.3 17 461 (x) 1,02 1,01 570 
EEF1AL3 IPI00472724.1 10 241 (x) 1,01 0,92 214 
NPM1 IPI00220740.1 5 331 (x) 1,01 1,01 205 
RBBP4 IPI00328319.8 5 73 (x) 1,01 0,96 184 
CCAR1 IPI00217357.2 15 77 (x) 1,01 1,01 311 
SF3A3 IPI00029764.1 16 437 (x) 1,00 0,92 468 
DHX9 IPI00844578.1 8 22 (x) 1,00 0,98 265 
RPL32 IPI00395998.5 7 1014 (x) 1,00 0,84 173 
ILF3 IPI00298788.4 5 45 (x) 0,99 0,93 160 
RPL9 IPI00031691.1 3 540 (x) 0,97 0,88 117 
ROCK1 IPI00022542.1 15 48 (x) 0,97 0,97 391 
SF3B4 IPI00017339.1 5 221 (x) 0,97 0,92 162 
VCP IPI00022774.3 7 57 (x) 0,97 0,93 150 
MATR3 IPI00017297.1 5 23 (x) 0,97 0,93 65 
DHX15 IPI00396435.3 9 67 (x) 0,95 0,93 216 
PRMT5 IPI00441473.3 72 5549 (x) 0,94 0,94 2221 
SF3B2 IPI00221106.5 33 558 (x) 0,94 0,99 879 
SF3B1 IPI00026089.3 27 281 (x) 0,94 0,92 613 
CMBL IPI00383046.3 1 11 (x) 0,93 0,89 2 
PABPC1 IPI00008524.1 4 41 (x) 0,93 0,8 174 
PRPF8 IPI00007928.4 21 33 (x) 0,93 0,84 687 
EFTUD2 IPI00003519.1 17 113 (x) 0,91 0,75 584 
SNRPB IPI00027285.1 6 383 (x) 0,89 0,97 122 
TUBA1C IPI00166768.3 7 164 (x) 0,89 0,94 311 
HIST1H4H IPI00453473.6 7 654 (x) 0,87 0,86 348 
TPP2 IPI00020416.8 28 196 (x) 0,87 0,77 995 
HSPA5 IPI00003362.2 17 139 (x) 0,87 0,74 457 
VIM IPI00418471.6 25 762 (x) 0,86 0,78 819 
SF3B3 IPI00300371.5 16 74 (x) 0,85 0,74 495 
PSMA4 IPI00299155.5 2 31 (x) 0,85 0,72 73 
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ACTB IPI00021439.1 1 3 (x) 0,84 0,7 81 
STK38L IPI00237011.5 16 43 (x) 0,83 0,77 445 
FLNA IPI00302592.2 17 35 (x) 0,83 0,69 499 
EPB41L3 IPI00032230.2 10 80 (x) 0,80 0,62 216 
CFL1 IPI00012011.6 8 532 (x) 0,79 0,58 206 
KIF11 IPI00305289.2 22 144 (x) 0,79 0,61 874 
OAT IPI00022334.1 4 27 (x) 0,78 0,6 100 
PRPF19 IPI00004968.1 4 112 (x) 0,78 0,61 96 
SNRPD1 IPI00302850.4 8 1023 (x) 0,78 0,84 296 
CLNS1A IPI00004795.1 8 354 (x) 0,77 0,59 346 
SNRPD2 IPI00017963.1 11 1519 (x) 0,77 0,71 223 
HIST2H3C IPI00171611.7 2 95 (x) 0,72 0,55 29 
CALM3 IPI00075248.11 4 371 (x) 0,69 0,49 195 
ACTA1 IPI00021428.1 8 1337 (x) 0,69 0,47 191 
LARP1 IPI00185919.3 7 7 (x) 0,68 0,53 168 
ASCC3L1 IPI00420014.2 19 37 (x) 0,61 0,95 624 
SNFPF IPI00220528.6 1 12 (x) 0,59 0,41 32 
HIST1H2BL IPI00018534.4 22 1016 (x) 0,39 0,25 780 
PRPSAP2 IPI00003168.1 2 1 (x) 0,16 0,1 55 
HIST2H2AA3 IPI00216457.7 24 1 (x) 0,07 0,05 735 
x: Indicates that the protein is found in the experiment with a SILAC ratio above background.(x): Indicates that the protein is found in the 
experiment, but with a SILAC ratio below background. 
To be able to compare protein intensities, the intensities are normalized to protein size (MW), since a large protein will contain more Arg 
or Lys containing peptides, than a smaller. The protein intensity/MW is calculated by summing the intensity of the heavy labelled 
peptides originating from a specific protein, and dividing this value with the molecular weight. 
Proteins with a SILAC ratio above 1 + 2 x average standard dev (for all proteins identified in this experiment) are believed to be true 
interaction partners. 
The "Protein score" is the summed peptide scores for a given protein 
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Supplementary Table S4. Oligonucleotides used in this study. “r” before sequence in brackets indicates 
that the oligo is composed of ribonucleotides. 
















generation of pHEX2 
HD3NFor 
CTCGAGCACCACCACCACCACCACTGAGATCCG generation of pHEX3 
-pHEX4 
HD3NRev 
TTATCATTCTTCAGACAAACAAGCAAGACGATCTATG generation of pHEX3
HD3LNRev 
TTACTAAAGGATAGAATCACAAAGCTCGTGGGCAGC generation of pHEX4 
HD3CFor 
ATGGGGAATGAAATAGAAAGTGGAAAAATAATATTTTCAG generation of pHEX5 
HD3CRev 
GGATCCACCGGTTTGTTCCTGGTAGACTTCAATCACATC generation of pHEX5 
-pHEX6 
HD3LCFor 
ATGCAGTCTCGACGGGAGAGAGAGAATGAGAGTCAGG generation of pHEX6 
D3PINF 
AGGAATAAccggGCGATTCGAGTAGCAGCAAAATGGTACAATG site-directed mutagenesis 
(hDIS3 D146N) 
D3PINR 
TCGAATCGCccggTTATTCCTGTCATTAGCATTTTCTCCCTG site-directed mutagenesis 
(hDIS3 D146N)
D3RNBF 
ATGTACTgatatcAACGATGCTCTACATTGTCGAGAACTCG site-directed mutagenesis 
(hDIS3 D487N)
D3RNBR 
AGCATCGTTgatatcAGTACATCCTGGTGGGTCTACACTAC site-directed mutagenesis 
(hDIS3 D487N)
D3LPINF 
TGATCCCcaattgGAAAGTTGTTCAAGATTATCTTGAGATCC site-directed mutagenesis 
(hDIS3L D62N)
D3LPINR 
















generation of pRS255 
RSZ143 CGATTACAAGGATGACGACGATAAGTAGGCTAGCGGCC generation of pRS201 
RSZ144 GCTAGCCTACTTATCGTCGTCATCCTTGTAATCGGGCC generation of pRS201 
RZS168 GCACTCGAGGGAGGATCCATGGAAAAGAG generation of pRS72 
RSZ169 CTGGGGCCCTCAGGTTGACTTCCCCGCGGA generation of pRS72 
dis3-tap-fw tgaggtaccATGCTCAAGTCCAAGACGTTC cloning of hDIS3 ORF into  
pcDNA5/FRT/TO-derived  
backbones (pRS255, pRS201 and  
pRS72) 
dis3-tap-rv tgactcgagTTTTCCAAGCTTCATCTTC cloning of hDIS3 ORF into  
pcDNA5/FRT/TO-derived  
backbones (pRS255, pRS201 and  
pRS72) 
dis3l-tap-fw tgaggtaccATGCTGCAGAAGCGGGAGAAG cloning of hDIS3L ORF into  
pcDNA5/FRT/TO-derived  
backbones (pRS255, pRS201 and  
pRS72) 
dis3l-tap-rv tgactcgagTATTCCATAATTGTTTGAAACATC cloning of hDIS3L ORF into  
pcDNA5/FRT/TO-derived  

























generation of pHEX34  
hD3Fdwn 




generation of pHEX35 
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hRRP6 BamHI FW  
aagcttggatccATGGCGCCACCCAGTACC generation of pHEX32 
hRRP6 FLAG NotI RE 
ctctaggcggccgcTCATTTATCGTCATCGTCTTTGTAGTCTCTCTGTGG
CCAGTTGTAC 
generation of pHEX32 
hRrp41 BamHI FW 
aagcttggatccATGGCGGGGCTGGAGCTCTTG generation of pHEX33 
hRrp41 FLAG NotI RE
ctctaggcggccgcTCATTTATCGTCATCGTCTTTGTAGTCGTCCCCCAG
CAAGATAGAGGC 
generation of pHEX33 
HD3F883 
GAAGATATTGTGGCTGTGGAGC sequencing of hDIS3 constructs 
HD3F1848 
CCGTGGACTGAATAAACTAGCC sequencing of hDIS3 constructs 
HD3F2429 
TGACAGACAAACACAAGCTTGC sequencing of hDIS3 constructs 
HD3R1021 
TTACAGCAGTCTTAAGCATTCG sequencing of hDIS3 constructs 
HD3R1592 
CTGGCTGATTCTTGATCCAAGG sequencing of hDIS3 constructs 
HD3R2443 
TGTGTTTGTCTGTCAACTCTGG sequencing of hDIS3 constructs 
E5rv 
AGCGTCCAGATTTAATCCCAGCT sequencing of hDIS3L constructs 
E5fw 
ACCTGGACAATTTCTGGCCTGAT sequencing of hDIS3L constructs 
E8fw 
CATACTTCAGAAGAACTGGCGGGA sequencing of hDIS3L constructs 
E11fw 
CCACTTATTATCTAGCAGATCGTCGC sequencing of hDIS3L constructs 
E13fw 
GTCCAATAAAACACTGGCTG sequencing of hDIS3L constructs 
E15fw 
CAGCACAGCATTCTCAGAAGC sequencing of hDIS3L  
constructs 
SumoF 
TCATACTGTCAAAGACAGGG amplification and sequencing of  
inserts in the  
pET-28M-6xHis-SUMOTag  
backbone 
RTADZ-54 GCTAGTTATTGCTCAGCGG amplification of inserts 
in the pET-28M-6xHis-SUMOTag 
RSZ-174 TCGTTTAGTGAACCGTCAG sequencing of inserts in the  
pcDNA5/FRT/TO backbone 
p415-left GTTTCCTCGTCATTGTTCTCG sequencing of inserts in the  
p415 backbone 
ss17-A14 r(CCCCACCACCAUCACUUAAAAAAAAAAAAAA) RNA oligonucleotide substrate  
used in biochemical assays 
ss17-A30 r(CCCCACCACCAUCACUUAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAA) 
RNA oligonucleotide substrate  
used in biochemical assays 
ss44 r(CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUA
GAAA) 
RNA oligonucleotide substrate  
used in biochemical assays 
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compl r(AAGUGAUGGUGGUGGGG) RNA oligonucleotide  
used in biochemical assays 
GAPDH (FW/RE) GTCAGCCGCATCTTCTTTTG/GCGCCCAATACGACCATC qPCR primer pair 
40-2 (FW/RE) GGGAGTCTAAGGAAAAGGAG/CAGTGAAAGGAGAGTATC qPCR primer pair 
40-13 (FW/RE) GGAAATAGTGGAGAAAAGCA/CATTTTTGAAGGAACGGTAG qPCR primer pair 
40-33 (FW/RE) CTGGCCTAGCTAAAGTCTCA/TCTGCTCCTAGCTCTCAGTC qPCR primer pair 
40-59 (FW/RE) CTTCTGAAGGGTTTTGTGTC/CGTGGCTTCATAGTC CTTAT qPCR primer pair 
MYC (FW/RE) TGCAGCCGTATTTCTACTG/TATCTGGAAGAAATTCGAGC qPCR primer pair 
FOS (FW/RE) GCCTGTCAACGCGCAGGACT/TCCGGTTGCGGCATTTGGCT qPCR primer pair 
dT primer GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTTVN primer for reverse transcription 
eGFP siRNA  
target (control) 
GACGUAAACGGCCACAAGU siRNA-mediated knock down 
TEL/AML siRNA  
target (control) 
GGAGAAUAGCAGAAUGCAU siRNA-mediated knock down 
hRRP6 siRNA target CCAGUUAUACAGACCUAUA siRNA-mediated knock down 
hDIS3 siRNA target AGGUAGAGUUGUAGGAAUA siRNA-mediated knock down 
hDIS3L siRNA target CGUAAAGACUUGAGGAAAA siRNA-mediated knock down 
hRRP40 siRNA target CACGCACAGUACUAGGUCA siRNA-mediated knock down 
5.8S rRNA oligo probe GTGTCGATGATCAATGTGTCCTGCAATTCA probe for northern-blot 
scR1 oligo probe  ATCCCGGCCGCCTCCATCAC probe for northern-blot 
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Supplementary Table S5. Plasmids used in this work.  
Plasmid Genotype 
pDrK [pDRIVE (Qiagen) with removed ScaI-NaeI fragment]
pRS255 [pcDNA5/FRT/TO (Invitrogen)] c-myc epitope
pRS201 [pcDNA5/FRT/TO (Invitrogen)] FLAG-tag 
pRS72 [pcDNA5/FRT/TO(Invitrogen)] TAP-tag
pHEX1 [pET-28M-6xHis-SUMOTag] hDIS3 FL WT
pHEX2 [pET-28M-6xHis-SUMOTag] hDIS3L FL WT
pHEX3 [pET-28M-6xHis-SUMOTag] hDIS3 Nterm WT
pHEX4 [pET-28M-6xHis-SUMOTag] hDIS3L Nterm WT
pHEX5 [pET-28M-6xHis-SUMOTag] hDIS3 Cterm WT
pHEX6 [pET-28M-6xHis-SUMOTag] hDIS3L Cterm WT
pHEX7 [pET-28M-6xHis-SUMOTag] hDIS3 FL PIN MUT (D146N)  
pHEX8 [pET-28M-6xHis-SUMOTag] hDIS3 FL RNB MUT (D487N)
pHEX9 [pET-28M-6xHis-SUMOTag] hDIS3 FL DM (D146N, D487N)
pHEX10 [pET-28M-6xHis-SUMOTag] hDIS3L FL PIN MUT (D62N)  
pHEX11 [pET-28M-6xHis-SUMOTag] hDIS3L FL RNB MUT (D486N)
pHEX12 [pET-28M-6xHis-SUMOTag] hDIS3L FL DM (D62N, D486N)
pHEX13 [pET-28M-6xHis-SUMOTag] hDIS3 Nterm PIN MUT (D146N) 
pHEX14 [pET-28M-6xHis-SUMOTag] hDIS3 Cterm RNB MUT (D487N) 
pHEX15 [pET-28M-6xHis-SUMOTag] hDIS3L Nterm PIN MUT (D62N) 
pHEX16 [pET-28M-6xHis-SUMOTag] hDIS3L Cterm RNB MUT (D486N) 
pHEX17 [pcDNA5/FRT/TO-myc] hDIS3L  WT
pHEX18 [pcDNA5/FRT/TO-FLAG] hDIS3 WT
pHEX19 [pcDNA5/FRT/TO-FLAG] hDIS3L WT
pHEX20 [pcDNA5/FRT/TO-TAP] hDIS3 WT
pHEX21 [pcDNA5/FRT/TO-TAP] hDIS3L WT
pHEX22 [p415] hDIS3 WT
pHEX23 [p415] hDIS3L WT
pHEX24 [p415] hDIS3 RNB MUT (D487N)
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pHEX25 [p415] hDIS3 PIN MUT (D146N)
pHEX26 [p415] hDIS3 DM (D146N, D487N)
pHEX27 [pcDNA5/FRT/TO-FLAG] hDIS3 RNB MUT (D487N)
pHEX28 [pcDNA5/FRT/TO-TAP] hDIS3 RNB MUT (D487N)
pHEX29 [pcDNA5/FRT/TO-TAP] hDIS3 DM (D146N, D487N)
pHEX30 [pcDNA5/FRT/TO-TAP] hDIS3L RNB MUT (D486N)
pHEX31 [pcDNA5/FRT/TO-TAP] hDIS3L DM (D62N, D486N)
pHEX32 [pcDNA5/FRT/TO-FLAG] hRRP6
pHEX33 [pcDNA5/FRT/TO-FLAG] hRRP41
pHEX34 [p415] hDIS3 WT-FLAG
pHEX35 [p415] hDIS3L WT-FLAG
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